ShareJunction - Stock Forum Messages

Zixin Last:0.031 -

China Star Food - The Strong Uptrend building

KHOO THOMAS CLIVE acquisition via market transaction
7300000 shares. SGD$0.03152 per share

https://links.sgx.com/1.0.0/corporate-announcements/NFKOMQG2IMKDE25U/859644__Khoo%20Thomas%20Clive%20-%20eForm3V2.pdf

whale khoo still bullish on purple potatoes..

https://links.sgx.com/1.0.0/corporate-announcements/NFKOMQG2IMKDE25U/d59a95de94a1ac007e0bcee68e1c100b62f856562dba2d6978b794f19d327f78

wonder when the roots reach gold deposits..

Haha. Leave out Khoo family. Threatening his position. Smart movement!

Bo lat liao

Time running out for last stuckis Please pushing and disaster coming October

Zixin given a target price of 60.

interesting..

https://www.theedgesingapore.com/capital/brokers-calls/liu-phillipcapital-maintains-buy-call-and-6-cents-target-price-zixin-group?utm_source=twitter& utm_medium=dlvr.it& utm_campaign=contentdistribution& utm_content=http%3A%2F%2Fprod.tes-api.com%2Fv1%2Fservice%2Frss%2Flatest-news-print-edition

Zixin Group plans to allocate share options at 3 cents each, potentially raising $26.67 mil

Zixin Group Holdings plans to grant 889 million share options with an exercise price of 3 cents to a group of investors led by executive chairman and CEO Liang Chengwang. The share options can be exercised up till five years from the issue date.

In total, if all the options are exercised, these investors will be chipping in up to $26.67 million.

Zixin shares closed at 3.2 cents on Sept 18.

Liang will be receiving 300 million share options, and other investors include both existing and new shareholders.

Thomas Clive Khoo, known to be a key shareholder of Zixin who has been steadily increasing his stake, is not among the investors receiving the options.

Khoo last increased his stake on May 27 when he bought 8 million shares at 3.3 cents each from the open market, bringing his stake to nearly 214.6 million shares, or 13.501%.

Liang, in contrast, holds just over 242.6 million shares, or 15.27%. If he exercises his entire option of 300 million shares, he will own over 542.6 million shares, equivalent to 21.89% of the company' s enlarged share capital.

This arrangement will require the approval of shareholders at an EGM to be called.

Zixin Group is a China-based foodstuffs manufacturer, focusing on sweet potato-based products.

The company explains that the majority of its cash on hand is held by its China-based entities, and thus channelling funds to its Singapore entities will be subject to the completion of the requisite administrative procedures and require processing time.

As such, Zixin is of the view that deploying part of the net proceeds as general capital would strengthen its cash position and its Singapore subsidiaries would be in a better position to pay ongoing expenses such as salary, rental and other professional fees.

The additional funds will also give Zixin more flexibility to finance its growth plans via new business opportunities.

If the share price drops below the option price, the option holders will not call for issuance and subscription. The problem is that there are interested parties amongst the option holders

Choot Pattern, Never Heard Of.

Why chose such an arrangement - option to issue, and option to subcribe for $1 consideration? How long the option period? Is it every call of the option is minimally 10% of the option amount? Why not a straight forward private placement? Anyone can clarify?

sklong138 ( Date: 19-Sep-2025 07:06) Posted:

Based on a careful review of the announcement, here is an impartial assessment of whether the proposed Share Option Agreement benefits the shareholders of Zixin Group Holdings.

Summary of the Transaction

The company has entered into an agreement with 11 investors, including its Executive Chairman (Liang Chengwang, " LCW" ) and its Financial Controller (Jee Meng Kwang, " JMK" ). The agreement creates a pair of reciprocal options:

1. Investor Options: The investors grant the company the right to force them to subscribe for up to 889 million new shares at S$0.030 per share.

2. Company Options: The company grants the investors the right to require the company to issue them those same 889 million new shares at S$0.030 per share.

The exercise price of S$0.030 represents a 4.51% discount to the VWAP of the shares just before the trading halt was called to announce this deal.

Assessment of Benefits to Shareholders

This transaction presents a mix of potential benefits and significant risks/drawbacks for shareholders.

Potential Benefits (Arguments For)

1. Secured Future Funding: The primary rationale stated by the company is to secure a commitment for future capital inflow at a fixed price. This provides certainty of funding for the company' s growth and expansion plans in China and Singapore, which could ultimately enhance shareholder value if executed successfully.

2. Immediate Capital Injection: Investors are obligated to exercise at least 10% of their options within 14 days of the grant date. This would provide the company with approximately S$2.67 million in immediate funds.

3. No Immediate Major Dilution: The structure defers dilution until the options are actually exercised, unlike a traditional placement which would cause immediate dilution.

4. Alignment of Management Interests: Granting options to key management (LCW and JMK) is intended to align their interests with those of shareholders by fostering an " ownership culture."

5. Avoids Reliance on " Out-of-the-Money" Warrants: The company notes that warrants from a previous rights issue are currently out of the money, so this new mechanism provides a more reliable potential funding source.

Significant Risks and Drawbacks (Arguments Against)

1. Substantial Potential Dilution: This is the most significant drawback. The issuance of 889 million new shares would increase the total number of shares by 55.94%. This will materially reduce the ownership percentage and voting power of existing shareholders who do not participate.

2. Dilution of Earnings (EPS): The financial effects show that fully exercising the options would reduce Earnings Per Share (EPS) from 2.75 RMB cents to 1.75 RMB cents, a dilution of 36.4%. Shareholders' claim on the company' s future earnings would be significantly reduced unless the injected capital generates a proportional increase in profit.

3. Discount to Market Price: The exercise price is set at a discount (4.51%) to the recent market price. While the company argues this was negotiated and reflects a " willing-buyer, willing-seller" dynamic, it inherently values new shares below the price available to existing shareholders in the market.

4. Interested Person Transaction (IPT) Concerns: The transaction with the Executive Chairman, LCW, is a major IPT. While it requires separate shareholder approval and he will abstain from voting, the deal significantly increases his influence. His potential stake could rise from 15.27% to a maximum of 20.64%, cementing his controlling shareholder status.

5. Conditional and Uncertain: The entire deal is subject to numerous conditions precedent, most importantly shareholder approval at an EGM. There is no certainty it will be completed.

6. Use of Proceeds is Somewhat Vague: A large portion (65%) is earmarked for " growth and expansion plans," which is a broad category. While 35% is for working capital, the announcement states the group already has sufficient working capital, which may lead shareholders to question the urgency and size of this fundraising.

Conclusion and Impartial Verdict

The proposed Share Option Agreement is a high-risk, high-potential reward strategy that does not unequivocally benefit all shareholders.

· It benefits the company as an entity by providing a structured and committed path to a significant capital raise (S$26.57m) intended for growth.

· It benefits the investors (especially LCW and JMK) by granting them a large option to increase their stake at a discounted price.

· For existing, non-participating shareholders, the benefits are indirect and speculative (future growth funded by the new capital), while the drawbacks are direct and certain (significant dilution of their ownership and earnings per share).

Whether this ultimately benefits shareholders depends entirely on the success of the company' s expansion plans. If the injected capital is used extremely effectively to generate profits that grow faster than the dilution, then shareholder value could increase. However, if the growth does not materialize or is lackluster, the massive dilution will have permanently reduced the value of each existing shareholder' s stake for little gain.

The board is asking shareholders to approve significant dilution today based on the promise of future growth tomorrow. Shareholders must carefully weigh the company' s track record and the specifics of its expansion plans before deciding if this risk is acceptable.

Recommendation for Shareholders: Vote in favor only if you have high confidence in management' s ability to deploy the S$26+ million effectively to generate returns that will outweigh the 36%+ dilution to your EPS. If you are skeptical about the growth plans or believe the dilution is too steep, you should vote against the resolutions at the forthcoming EGM.

Some contra due selling at 30 i queue another 1m at 30 see cam get

Kilatkilat ( Date: 19-Sep-2025 10:59) Posted:

Temporary sentiment. Now got investorss wanted to go in big at 3, why existing holders feel worry? Should be happy.

buy open market maybe cheaper.. will got back to 2 series soon.. haha.. crap company..

piscesmonkey ( Date: 19-Sep-2025 10:28) Posted:

Boss Khoo nv buy at placement? He like to buy at open market? 👍

Too many scripts floating after the placement. Even with good profits there won't be dividends declared with too many scripts. DYODD

LoudShout ( Date: 19-Sep-2025 08:47) Posted:

If management is so confident on growth, why issued at a discount esp considering the existing warrant exercise price? Warrant holders would be disadvantaged. Why not go for debt financing if the prospect is so glowing? The IPT does not look good, but that is to expect from S Chip.

sklong138 ( Date: 19-Sep-2025 07:06) Posted:

Based on a careful review of the announcement, here is an impartial assessment of whether the proposed Share Option Agreement benefits the shareholders of Zixin Group Holdings.

Summary of the Transaction

The company has entered into an agreement with 11 investors, including its Executive Chairman (Liang Chengwang, " LCW" ) and its Financial Controller (Jee Meng Kwang, " JMK" ). The agreement creates a pair of reciprocal options:

1. Investor Options: The investors grant the company the right to force them to subscribe for up to 889 million new shares at S$0.030 per share.

2. Company Options: The company grants the investors the right to require the company to issue them those same 889 million new shares at S$0.030 per share.

The exercise price of S$0.030 represents a 4.51% discount to the VWAP of the shares just before the trading halt was called to announce this deal.

Assessment of Benefits to Shareholders

This transaction presents a mix of potential benefits and significant risks/drawbacks for shareholders.

Potential Benefits (Arguments For)

1. Secured Future Funding: The primary rationale stated by the company is to secure a commitment for future capital inflow at a fixed price. This provides certainty of funding for the company' s growth and expansion plans in China and Singapore, which could ultimately enhance shareholder value if executed successfully.

2. Immediate Capital Injection: Investors are obligated to exercise at least 10% of their options within 14 days of the grant date. This would provide the company with approximately S$2.67 million in immediate funds.

3. No Immediate Major Dilution: The structure defers dilution until the options are actually exercised, unlike a traditional placement which would cause immediate dilution.

4. Alignment of Management Interests: Granting options to key management (LCW and JMK) is intended to align their interests with those of shareholders by fostering an " ownership culture."

5. Avoids Reliance on " Out-of-the-Money" Warrants: The company notes that warrants from a previous rights issue are currently out of the money, so this new mechanism provides a more reliable potential funding source.

Significant Risks and Drawbacks (Arguments Against)

1. Substantial Potential Dilution: This is the most significant drawback. The issuance of 889 million new shares would increase the total number of shares by 55.94%. This will materially reduce the ownership percentage and voting power of existing shareholders who do not participate.

2. Dilution of Earnings (EPS): The financial effects show that fully exercising the options would reduce Earnings Per Share (EPS) from 2.75 RMB cents to 1.75 RMB cents, a dilution of 36.4%. Shareholders' claim on the company' s future earnings would be significantly reduced unless the injected capital generates a proportional increase in profit.

3. Discount to Market Price: The exercise price is set at a discount (4.51%) to the recent market price. While the company argues this was negotiated and reflects a " willing-buyer, willing-seller" dynamic, it inherently values new shares below the price available to existing shareholders in the market.

4. Interested Person Transaction (IPT) Concerns: The transaction with the Executive Chairman, LCW, is a major IPT. While it requires separate shareholder approval and he will abstain from voting, the deal significantly increases his influence. His potential stake could rise from 15.27% to a maximum of 20.64%, cementing his controlling shareholder status.

5. Conditional and Uncertain: The entire deal is subject to numerous conditions precedent, most importantly shareholder approval at an EGM. There is no certainty it will be completed.

6. Use of Proceeds is Somewhat Vague: A large portion (65%) is earmarked for " growth and expansion plans," which is a broad category. While 35% is for working capital, the announcement states the group already has sufficient working capital, which may lead shareholders to question the urgency and size of this fundraising.

Conclusion and Impartial Verdict

The proposed Share Option Agreement is a high-risk, high-potential reward strategy that does not unequivocally benefit all shareholders.

· It benefits the company as an entity by providing a structured and committed path to a significant capital raise (S$26.57m) intended for growth.

· It benefits the investors (especially LCW and JMK) by granting them a large option to increase their stake at a discounted price.

· For existing, non-participating shareholders, the benefits are indirect and speculative (future growth funded by the new capital), while the drawbacks are direct and certain (significant dilution of their ownership and earnings per share).

Whether this ultimately benefits shareholders depends entirely on the success of the company' s expansion plans. If the injected capital is used extremely effectively to generate profits that grow faster than the dilution, then shareholder value could increase. However, if the growth does not materialize or is lackluster, the massive dilution will have permanently reduced the value of each existing shareholder' s stake for little gain.

The board is asking shareholders to approve significant dilution today based on the promise of future growth tomorrow. Shareholders must carefully weigh the company' s track record and the specifics of its expansion plans before deciding if this risk is acceptable.

Recommendation for Shareholders: Vote in favor only if you have high confidence in management' s ability to deploy the S$26+ million effectively to generate returns that will outweigh the 36%+ dilution to your EPS. If you are skeptical about the growth plans or believe the dilution is too steep, you should vote against the resolutions at the forthcoming EGM.

Later 31 will be sold out. Today may see 35

piscesmonkey ( Date: 19-Sep-2025 09:00) Posted:

Bought 1.5m at 31 huge placement going up liao

If management is so confident on growth, why issued at a discount esp considering the existing warrant exercise price? Warrant holders would be disadvantaged. Why not go for debt financing if the prospect is so glowing? The IPT does not look good, but that is to expect from S Chip.

sklong138 ( Date: 19-Sep-2025 07:06) Posted:

Based on a careful review of the announcement, here is an impartial assessment of whether the proposed Share Option Agreement benefits the shareholders of Zixin Group Holdings.

Summary of the Transaction

The company has entered into an agreement with 11 investors, including its Executive Chairman (Liang Chengwang, " LCW" ) and its Financial Controller (Jee Meng Kwang, " JMK" ). The agreement creates a pair of reciprocal options:

1. Investor Options: The investors grant the company the right to force them to subscribe for up to 889 million new shares at S$0.030 per share.

2. Company Options: The company grants the investors the right to require the company to issue them those same 889 million new shares at S$0.030 per share.

The exercise price of S$0.030 represents a 4.51% discount to the VWAP of the shares just before the trading halt was called to announce this deal.

Assessment of Benefits to Shareholders

This transaction presents a mix of potential benefits and significant risks/drawbacks for shareholders.

Potential Benefits (Arguments For)

1. Secured Future Funding: The primary rationale stated by the company is to secure a commitment for future capital inflow at a fixed price. This provides certainty of funding for the company' s growth and expansion plans in China and Singapore, which could ultimately enhance shareholder value if executed successfully.

2. Immediate Capital Injection: Investors are obligated to exercise at least 10% of their options within 14 days of the grant date. This would provide the company with approximately S$2.67 million in immediate funds.

3. No Immediate Major Dilution: The structure defers dilution until the options are actually exercised, unlike a traditional placement which would cause immediate dilution.

4. Alignment of Management Interests: Granting options to key management (LCW and JMK) is intended to align their interests with those of shareholders by fostering an " ownership culture."

5. Avoids Reliance on " Out-of-the-Money" Warrants: The company notes that warrants from a previous rights issue are currently out of the money, so this new mechanism provides a more reliable potential funding source.

Significant Risks and Drawbacks (Arguments Against)

1. Substantial Potential Dilution: This is the most significant drawback. The issuance of 889 million new shares would increase the total number of shares by 55.94%. This will materially reduce the ownership percentage and voting power of existing shareholders who do not participate.

2. Dilution of Earnings (EPS): The financial effects show that fully exercising the options would reduce Earnings Per Share (EPS) from 2.75 RMB cents to 1.75 RMB cents, a dilution of 36.4%. Shareholders' claim on the company' s future earnings would be significantly reduced unless the injected capital generates a proportional increase in profit.

3. Discount to Market Price: The exercise price is set at a discount (4.51%) to the recent market price. While the company argues this was negotiated and reflects a " willing-buyer, willing-seller" dynamic, it inherently values new shares below the price available to existing shareholders in the market.

4. Interested Person Transaction (IPT) Concerns: The transaction with the Executive Chairman, LCW, is a major IPT. While it requires separate shareholder approval and he will abstain from voting, the deal significantly increases his influence. His potential stake could rise from 15.27% to a maximum of 20.64%, cementing his controlling shareholder status.

5. Conditional and Uncertain: The entire deal is subject to numerous conditions precedent, most importantly shareholder approval at an EGM. There is no certainty it will be completed.

6. Use of Proceeds is Somewhat Vague: A large portion (65%) is earmarked for " growth and expansion plans," which is a broad category. While 35% is for working capital, the announcement states the group already has sufficient working capital, which may lead shareholders to question the urgency and size of this fundraising.

Conclusion and Impartial Verdict

The proposed Share Option Agreement is a high-risk, high-potential reward strategy that does not unequivocally benefit all shareholders.

· It benefits the company as an entity by providing a structured and committed path to a significant capital raise (S$26.57m) intended for growth.

· It benefits the investors (especially LCW and JMK) by granting them a large option to increase their stake at a discounted price.

· For existing, non-participating shareholders, the benefits are indirect and speculative (future growth funded by the new capital), while the drawbacks are direct and certain (significant dilution of their ownership and earnings per share).

Whether this ultimately benefits shareholders depends entirely on the success of the company' s expansion plans. If the injected capital is used extremely effectively to generate profits that grow faster than the dilution, then shareholder value could increase. However, if the growth does not materialize or is lackluster, the massive dilution will have permanently reduced the value of each existing shareholder' s stake for little gain.

The board is asking shareholders to approve significant dilution today based on the promise of future growth tomorrow. Shareholders must carefully weigh the company' s track record and the specifics of its expansion plans before deciding if this risk is acceptable.

Recommendation for Shareholders: Vote in favor only if you have high confidence in management' s ability to deploy the S$26+ million effectively to generate returns that will outweigh the 36%+ dilution to your EPS. If you are skeptical about the growth plans or believe the dilution is too steep, you should vote against the resolutions at the forthcoming EGM.

Let's wait for the opening bell and see what direction the prices are going.

Goodgoing ( Date: 19-Sep-2025 08:29) Posted:

Profitable but no dividends. First warrants exercise price at 0.045, now share option price at 0.03.....

Login Register

China Star Food - The Strong Uptrend building